Trial Protocol GlobiFer - Oral Iron Repletion (TPG)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 60 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
female , ≥ 18 ≤ 60 years of age
≥ 18 ≤ 60 years of age
Signed written informed consent
Hb ≥ 8 ≤ 10g/dl for
History of acquired iron overload, known haemochromatosis or first relatives with haemochromatosis, and allergic disorders (asthma, eczema, and anaphylactic reactions).
Known hypersensitivity to oral iron preparations.
Diseases, which an iron supplementation is not allowed or contraindicated.
Patients on current oral or intravenous iron supplementation
History of erythropoietin therapy in previous 30 days or scheduled for erythropoietin therapy or blood transfusion during duration of the study.
Patients who have had iron supplementation within the last 30 days.
Other reasons which in the investigator's judgment argue against inclusion of the patient into the trial.
Inability to comprehend study protocol
Participation in another clinical trial (currently or within the last 30 days)